Buvidal is a medicine used to treat dependence on opioid (narcotic) drugs such as heroin or morphine. Buvidal is used in adults and adolescents aged over 16 years who are also receiving medical, social and psychological support. Buvidal contains the active substance buprenorphine and is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance, but Buvidal is given in a different way. The reference medicine for Buvidal is Subutex. While Subutex is available as sublingual tablets (tablets to be placed under the tongue), Buvidal is available as a solution for injection under the skin.
Therapeutic Indication
### Therapeutic indication Treatment of opioid dependence within a framework of medical, social and psychological treatment. Treatment is intended for use in adults and adolescents aged 16 years or over.
Therapeutic Area (MeSH)
ATC Code
N07BC01
ATC Item
buprenorphine
Pharmacotherapeutic Group
Other nervous system drugs
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| buprenorphine | N/A | 丁丙诺啡 |
EMA Name
Buvidal
Medicine Name
Buvidal
Aliases
N/ANo risk management plan link.